Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders
Mahmoud E. Soliman · 2026
Read Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders by Mahmoud E. Soliman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13566856.txt.
Description
Soliman wrote a solo paper presenting a drug design software platform, in work from twenty twenty-six. Network pharmacology views drugs as acting on protein networks, not single targets. A typical study is fragmented, though, forcing researchers to juggle many databases and standalone tools.
Drug Design Studio version two aims to unify that workflow in one platform. It joins target collection, network building, docking, and virtual screening for both covalent and non covalent binders. One environment cuts setup errors and file conversion pain. The paper is a tool announcement for computational drug discovery groups.
Catalog record
| CREATOR | Mahmoud E. Soliman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |